CHAPTERS Group AG header image

CHAPTERS Group AG

CHG

Equity

ISIN DE0006618309 / Valor 2175722

Xetra (2025-11-19)
EUR 35.90+1.13%

CHAPTERS Group AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CHAPTERS Group AG, formerly known as Medical Columbus, started as a software startup in 1998 with a focus on improving procurement processes in German hospitals. Over the years, the company evolved into a leading provider in the healthcare market before selling its core business to a strategic buyer. Today, CHAPTERS Group AG operates as a holding company investing in small- and mid-sized enterprises across various sectors. With a long-term investment approach, the publicly traded company aims to provide permanent capital to its portfolio companies, enabling them to develop and grow continuously while delivering value to investors over decades.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.11.2025):

CHAPTERS Group AG’s Interim Report for June 2024 showcases significant growth and strategic momentum. The report highlights an expanded operating portfolio—now comprising 46 companies—and solid financial performance with consolidated revenue reaching approximately €58.4 million and an EBITDA of over €13 million. The company continues to strengthen its decentralized model, underpinned by robust governance and risk management, while its increased invested capital of more than €198 million (bolstered by an €85 million capital raise in August 2024) supports its mission-critical cybersecurity and software solutions initiatives.

Operating Expansion

The group has grown considerably, now overseeing 46 operating companies across several European markets. This expansion comes as part of its strategy to build a home for mission-critical businesses and to support platforms like Ookam Software, with acquisitions across Germany, Austria, the Czech Republic, Slovakia, Spain, and Switzerland reinforcing its market presence.

Robust Financial Performance

The June 2024 results show consolidated revenue of approximately €58.4 million and an EBITDA figure exceeding €13 million. These figures reflect both the organic growth of established operations and the successful integration of new acquisitions, underscoring the company’s resilient financial foundation.

Strategic Investments & Developments

CHAPTERS Group AG continues to drive its strategic agenda with key investments and acquisitions. The increased stake in Ookam Software, the establishment of new platforms like Waterkant Software GmbH and Altamount, and the ongoing capital increase all signal a strong commitment to underpinning further inorganic growth and enhancing decentralized leadership and accountability across the group.

Summarized from source with an LLMView Source

Key figures

50.8%1Y
192%3Y
645%5Y

Performance

42.7%1Y
38.4%3Y
44.3%5Y

Volatility

Market cap

970 M

Market cap (USD)

Daily traded volume (Shares)

10,675

Daily traded volume (Shares)

1 day high/low

25 / 24.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.22%EUR 26.48
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%EUR 9.03
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%EUR 26.45
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%EUR 110.65
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.79%EUR 46.69
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%EUR 39.52
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%EUR 35.30
AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 232.91
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 24.88
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%USD 70.53